Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Astellas May Abandon Chase for CV Therapeutics, Analysts Say
Astellas May Abandon Chase for CV Therapeutics, Analysts Say
Astellas May Abandon Chase for CV Therapeutics, Analysts Say
Submitted by
admin
on March 13, 2009 - 6:49am
Source:
Bloomberg
News Tags:
Astellas
buyouts
CV Therapeutics
Gilead Sciences
Headline:
Astellas May Abandon Chase for CV Therapeutics, Analysts Say
Do Not Allow Advertisers to Use My Personal information
